News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current PPH market cap is 493.16M. The company's latest EPS is USD 17.1336 and P/E is 5.34.
| Quarter End | Mar 2012 | ||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.38M | ||||
| Operating Income | 0 | ||||
| Net Income | 2.12M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.3M | 4.21M | 5.62M | 8.92M | 10.39M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -25.57M | 28.27M | 41.02M | -57.82M | 92.32M |
| Quarter End | Mar 2012 | ||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 262.54M | ||||
| Total Liabilities | 1.24M | ||||
| Total Equity | 261.29M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 150.04M | 237.56M | 340M | 580.24M | 448.42M |
| Total Liabilities | 8.38M | 2.41M | 21.06M | 56.5M | 18.37M |
| Total Equity | 141.66M | 235.15M | 318.94M | 523.74M | 430.05M |
| Market Cap | 493.16M |
| Price to Earnings Ratio | 5.34 |
| Price to Sales Ratio | 47.44 |
| Price to Cash Ratio | 1.84k |
| Price to Book Ratio | 1.15 |
| Dividend Yield | - |
| Shares Outstanding | 5.39M |
| Average Volume (1 week) | 118.17k |
| Average Volume (1 Month) | 132.96k |
| 52 Week Change | 19.12% |
| 52 Week High | 93.44 |
| 52 Week Low | 74.05 |
| Spread (Intraday) | 0.26 (0.28%) |
| Company Name | VanEck Pharmaceuticals ETF |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vaneck.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
